HCA Healthcare, Inc.
HCA
Rank in Stocks
#234
HCA Healthcare, Inc., operating through its subsidiaries, delivers a... HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally offer a broad range of outpatient care, such as ambulatory surgery, laboratory testing, radiology, respiratory therapy, cardiology, and physical therapy. Beyond its hospital infrastructure, HCA Healthcare operates numerous specialized outpatient facilities. These include standalone ambulatory surgery centers, dedicated emergency care facilities, urgent care clinics, walk-in clinics, advanced diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology treatment facilities, physician practices, and various other healthcare sites. Furthermore, the company oversees psychiatric hospitals, which offer diverse therapeutic programs. These services cater to child, adolescent, and adult psychiatric care, alongside adolescent and adult alcohol and drug abuse treatment and counseling. As of December 31, 2021, HCA Healthcare's extensive portfolio included 182 hospitals, specifically 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals. Its network also featured 125 freestanding surgery centers and 21 freestanding endoscopy centers, all distributed across 20 states and England. Founded in 1968 and formerly known as HCA Holdings, Inc., the company's corporate headquarters are situated in Nashville, Tennessee.
Share Price
$455.61
Market Cap
$98.64B
Change (1 day)
-0.42%
Change (1 year)
6.91%
Country
US
Trade HCA Healthcare, Inc. (HCA)
Category
Healthcare
P/E ratio for HCA Healthcare, Inc. (HCA)
P/E ratio as of October 2026 TTM: 15.70
According to HCA Healthcare, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 15.70. At the end of 2024 the company had a P/E ratio of 13.48.
P/E ratio history for HCA Healthcare, Inc. from 2000 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 15.70 | -1.12% |
| 2025 | 15.88 | 17.82% |
| 2024 | 13.48 | -4.20% |
| 2023 | 14.07 | 13.93% |
| 2022 | 12.35 | 3.39% |
| 2021 | 11.94 | -19.42% |
| 2020 | 14.82 | 2.99% |
| 2019 | 14.39 | 27.70% |
| 2018 | 11.27 | -18.80% |
| 2017 | 13.88 | 46.23% |
| 2016 | 9.49 | -25.08% |
| 2015 | 12.67 | -23.04% |
| 2014 | 16.46 | 22.10% |
| 2013 | 13.48 | 61.79% |
| 2012 | 8.33 | 95.59% |
| 2011 | 4.26 | -61.13% |
| 2010 | 10.96 | 8.90% |
| 2009 | 10.06 | -36.15% |
| 2008 | 15.76 | 29.87% |
| 2007 | 12.14 | 0.47% |
| 2006 | 12.08 | 26.01% |
| 2005 | 9.59 | -19.05% |
| 2004 | 11.84 | 1.54% |
| 2003 | 11.66 | -38.72% |
| 2002 | 19.03 | 3.68% |
| 2001 | 18.36 | -76.33% |
| 2000 | 77.55 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| 10.40 | -33.78% |
US
|
|
| 32.07 | 104.23% |
SA
|
|
| 20.00 | 27.37% |
BR
|
|
| - | - |
MY
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.